IMRIS (IMRSQ) Institutional Ownership : 0.55% (As of May. 16, 2024)

View and export this data going back to 2010. Start your Free Trial

What is IMRIS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IMRIS's institutional ownership is 0.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IMRIS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IMRIS's Float Percentage Of Total Shares Outstanding is 64.70%.

IMRIS Institutional Ownership Historical Data

The historical data trend for IMRIS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS Institutional Ownership Chart

IMRIS Historical Data

The historical data trend for IMRIS can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	0.55	0.55	0.55	0.55	0.55	0.55	0.55	0.55	0.55	0.55

IMRIS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

IMRIS (IMRSQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (GREY:IMRSQ) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5

Website

http://www.imris.com

IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (IMRSQ) Headlines

No Headlines